HAEMATO AG

HAEMATO AG
Stock Exchange Xetra Stock Exchange
EPS
EUR0.28
Market Cap
EUR113.88 M
Shares Outstanding
22.87 M
Public Float
10.97 M

Profile

Address
Lilienthalstraße 5c
Schönefeld Brandenburg 12529
Germany
Employees -
Website http://haemato.de
Updated 07/08/2019
Haemato AG engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes therapies for cancer, HIV, rheumatology, and other chronic diseases. It also consists of products for the privately financed market for aesthetic treatments.

Financials

View All
Created with Highcharts 5.0.14HAEMATO AGNet Income. Fiscal year is January-December. All values EUR Thousands.7 9407 9406 9786 9785 5395 53911 03611 0366 9826 9826 2766 27620132014201520162017201802.5k5k7.5k10k12.5k
Created with Highcharts 5.0.14HAEMATO AGSales/Revenue. Fiscal year is January-December. All values EUR Thousands.173 566173 566202 674202 674229 727229 727275 613275 613289 862289 862274 100274 100201320142015201620172018050k100k150k200k250k300k350k

Andrea Grosse
Chairman-Supervisory Board
Marion Braun
Member-Supervisory Board